15. A major advantage of the hybrid closed-loop system is that it
Answer: B
provides automated monitoring and insulin dosing with minimal input from the patient.
The hybrid closed-loop system offers significant advantages by automating the monitoring of blood glucose levels and the delivery of insulin, which reduces the need for constant patient intervention. This streamlined process allows individuals with type 1 diabetes to manage their condition more effectively and with greater ease.
A) keeps the patient disciplined about diet and treatment.
This option incorrectly emphasizes discipline in diet and treatment as a primary advantage of the hybrid closed-loop system. While maintaining a proper diet is important for diabetes management, the system itself is designed to automate processes, thereby reducing the burden of discipline on the patient rather than enforcing it.
B) provides automated monitoring and insulin dosing with minimal input from the patient.
This option accurately describes a key benefit of the hybrid closed-loop system. By automating insulin dosing based on real-time glucose monitoring, the system allows patients to experience more convenient and effective diabetes management without the constant need for manual adjustments.
C) eliminates the need for consistent treatment.
This statement is misleading as the hybrid closed-loop system does not eliminate the need for consistent treatment; rather, it enhances the management of such treatment. Patients still require insulin and monitoring, but the system improves how these are delivered and tracked.
D) results in fewer hospitalizations related to management of T1D.
While the hybrid closed-loop system may contribute to better overall management and potentially reduce complications, it does not guarantee fewer hospitalizations. Hospitalization can depend on various factors beyond just the technology used for management, such as the individual's overall health and access to care.
Conclusion
The hybrid closed-loop system stands out primarily for its ability to automate insulin dosing and glucose monitoring, significantly minimizing the patient's active role in these processes. This automation is crucial in improving the quality of life for individuals managing type 1 diabetes, while other options either misrepresent the system's capabilities or overlook its critical advantages.